[Physician in the pharmaceutical industry].

Internist (Berl)

Published: March 2000

Download full-text PDF

Source
http://dx.doi.org/10.1007/s001080050510DOI Listing

Publication Analysis

Top Keywords

[physician pharmaceutical
4
pharmaceutical industry]
4
[physician
1
industry]
1

Similar Publications

Whether preoperative chemoradiotherapy (CRT) or perioperative chemotherapy is superior for localized esophageal or gastro-esophageal junction (GEJ) cancers has been a topic of long-standing debate. For years, standard of care in the United States for localized esophageal or GEJ adenocarcinoma (EAC) has been physician's choice between the 2 strategies. More recently, adjuvant immunotherapy has also been introduced into the treatment approach for those who received neoadjuvant CRT.

View Article and Find Full Text PDF

Network Analyses to Explore Comorbidities Among Older Adults Living With Dementia.

J Am Geriatr Soc

January 2025

Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Background: Older persons living with dementia (PLWD) often have multiple other chronic health conditions (i.e., comorbidities).

View Article and Find Full Text PDF

Changes in doxylamine-pyridoxine dispensation in Ontario following media attention: Time-series analysis.

Can Fam Physician

January 2025

Assistant Professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto, Scientist at Women's College Hospital Institute for Health System Solutions and Virtual Care in Toronto, Investigator with the Ontario Drug Policy Research Network, and Adjunct Scientist at ICES.

Objective: To understand the possible association between media coverage and changes in the dispensation of doxylamine-pyridoxine in Canada.

Design: Cross-sectional time-series analysis using data from the IQVIA CompuScript database.

Setting: Ten Canadian provinces.

View Article and Find Full Text PDF

Hypertension, dyslipidemia, and type 2 diabetes are highly prevalent and poorly controlled cardiometabolic diseases in the Middle East. Therapeutic non-adherence and therapeutic inertia are major contributors to this suboptimal disease control. Regardless of the cardiometabolic disease, evidence-based solutions may be used to improve therapeutic non-adherence and overcome inertia, and thereby help to alleviate the heavy burden of cardiovascular disease in the Middle East.

View Article and Find Full Text PDF

Background: There is no definitive solution for the treatment of striae distensae (SD), and effectiveness of each treatment method remains controversial. We aimed to investigate and compare the efficacy of the combination of Erbium YAG (Er:YAG) laser and stromal vascular fraction (SVF), the combination of Er:YAG laser and platelet-rich plasma (PRP) and Er:YAG laser plus saline in the treatment of SD.

Materials And Methods: In 12 participating patients with at least three lesions (36 lesions in total), each lesion was treated with an Er:YAG laser.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!